KDM6B and esophageal cancer: Moreover, the knockdown of KDM6B led to reduced levels of stemness markers, i.e., the reduced expression of CD44, Bmi1, Nanog, and Oct4, and diminished the proportion of side population cells in esophageal cancer cells [46].